NFLX
58
4
STI
49
2
PLD
58
2
CMG
41
3
PCG
54
-4
L
67
3
BEN
55
-2
XYL
33
-2
ED
50
-9
AZO
48
-2
SRE
68
2
QRVO
59
6
DAL
66
-2
AMG
57
-3
PPL
77
2
WDC
66
-2
CTAS
27
3
JCI
51
-3
SWKS
37
6
CVS
52
2
NFLX
58
4
STI
49
2
PLD
58
2
CMG
41
3
PCG
54
-4
L
67
3
BEN
55
-2
XYL
33
-2
ED
50
-9
AZO
48
-2
SRE
68
2
QRVO
59
6
DAL
66
-2
AMG
57
-3
PPL
77
2
WDC
66
-2
CTAS
27
3
JCI
51
-3
SWKS
37
6
CVS
52
2
Financhill
Back

ERShares Private-Public Crossover ETF Vs. Apogee Therapeutics, Inc. Industry Stock Comparison

Sell
35

XOVR
ERShares Private-Public Crossover ETF

Last Price:
$17.00
Seasonality Move:
6.96%
Sell
44

APGE
Apogee Therapeutics, Inc.

Last Price:
$84.40
Seasonality Move:
-11.77%
Sell
35
ERShares Private-Public Crossover ETF (XOVR) is a Sell

Is ERShares Private-Public Crossover ETF a Buy, Sell or Hold?

  • The current ERShares Private-Public Crossover ETF [XOVR] share price is $17.00. The Score for XOVR is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • XOVR is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
44
Apogee Therapeutics, Inc. (APGE) is a Sell

Is Apogee Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Apogee Therapeutics, Inc. [APGE] share price is $84.34. The Score for APGE is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • APGE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

XOVR Stock Price Chart

What is ERShares Private-Public Crossover ETF's stock price today?

  • The ERShares Private-Public Crossover ETF share price today is $17.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and XOVR is experiencing buying pressure, which is a positive indicator for future bullish movement.

APGE Stock Price Chart

What is Apogee Therapeutics, Inc.'s stock price today?

  • The Apogee Therapeutics, Inc. share price today is $84.34
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APGE is experiencing buying pressure, which is a positive indicator for future bullish movement.

XOVR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.26 Sell
Relative Strength Index (14 RSI): 44.51 Sell
Chaikin Money Flow: 1375956 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (16.91 - 17.63) Sell
Bollinger Bands (100): (17.5 - 20.22) Sell

APGE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.18 Buy
Relative Strength Index (14 RSI): 64.96 Buy
Chaikin Money Flow: 432550 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (69.1 - 79.44) Buy
Bollinger Bands (100): (66.23 - 78.47) Buy

XOVR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 16.85 Buy
20-day SMA: 17.19 Sell
50-day SMA: 17.65 Sell
200-day SMA: 19.49 Sell
8-day EMA: 16.92 Buy
20-day EMA: 17.13 Sell
50-day EMA: 17.74 Sell
200-day EMA: 18.73 Sell

APGE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 79.91 Buy
20-day SMA: 75.21 Buy
50-day SMA: 71.36 Buy
200-day SMA: 57.28 Buy
8-day EMA: 80.37 Buy
20-day EMA: 76.41 Buy
50-day EMA: 73.33 Buy
200-day EMA: 61.58 Buy

ERShares Private-Public Crossover ETF Earnings Growth & XOVR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apogee Therapeutics, Inc. Earnings Growth & APGE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.08 per share, a decrease next quarter of $0.21 per share, a decrease this year of $0.63 per share, and a decrease next year of $0.62 per share.

ERShares Private-Public Crossover ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Apogee Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):